NexgenRx Inc.
NEGXF
$0.20
$0.00351.78%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 369.53% | -93.19% | 220.01% | -192.21% | -1,423.44% |
| Total Depreciation and Amortization | -3.57% | -0.42% | 0.98% | -2.46% | -4.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.29% | -15.49% | -109.79% | 1,467.92% | 40.45% |
| Change in Net Operating Assets | -148.88% | 148.88% | -455.96% | -30.91% | 74.36% |
| Cash from Operations | -86.53% | 284.56% | -233.69% | -44.72% | 14.99% |
| Capital Expenditure | 75.11% | -64.23% | -57.47% | 78.09% | -845.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.31% | -200.00% | -- | -- | -- |
| Cash from Investing | 57.54% | -158.57% | -416.09% | 78.09% | 69.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.96% | -16.43% | 24.18% | -57.80% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 91.46% | -1,056.33% | 92.04% | -1,150.81% | 92.09% |
| Other Financing Activities | -200.00% | -- | -- | -- | -- |
| Cash from Financing | 92.05% | -623.25% | 116.14% | -3,702.20% | 102.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.16% | 185.70% | -759.55% | -108.94% | 12,661.54% |
